CJC-1295 without DAC 5mg + Ipamorelin 5mg
This combination blend pairs CJC-1295 (without DAC) with Ipamorelin, formulated for researchers studying combined GHRH and ghrelin receptor agonism on pulsatile growth hormone release.
Research Applications
- Combined GHRH/ghrelin receptor signalling research
- Synergistic growth hormone pulse-release studies
- Comparative research against single-compound GH secretagogue protocols
Compound Information
Blend of CJC-1295 without DAC (5mg) and Ipamorelin (5mg). Supplied as lyophilised powder.
Technical Specifications
A blend of CJC-1295 (without DAC) and Ipamorelin - see each compound's individual listing for its own molecular data.
For laboratory research use only. Not for human or veterinary use. Not a drug, food, cosmetic, or dietary supplement, and not evaluated by the MHRA or any regulatory body for safety or efficacy. Buyers are responsible for ensuring their use complies with applicable laws and regulations.